ScreenPro Announces Acquisition of Naturevan Nutrition Ltd.
Toronto, Ontario–(Newsfile Corp. – May 13, 2022) – ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF)…
News
United States: TotalEnergies Wins Maritime Lease to Develop a 1 GW Offshore Wind Farm off North Carolina’s Coast
PARIS–(BUSINESS WIRE)–Regulatory News: TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) has been named a winner by the Bureau…
Simpson Thacher Adds Prominent Real Estate Finance Partner
LONDON & NEW YORK–(BUSINESS WIRE)–Simpson Thacher & Bartlett LLP today announced that James Esterkin will…
Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal, on the Results of the Phase III Research of Dorzagliatin, a First-In-Class Investigational Diabetes Drug of Hua Medicine
SHANGHAI, CHINA, May 13, 2022 – (ACN Newswire) – Hua Medicine (the “Company”, stock code…
Avicanna Reports Q1 2022 Financial Statement and Management Change
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
Strategy Analytics: Telecom Operators Need to Build Differentiated Competitiveness to Extend Their Business Scope
It’s time for telecom operators to set their transformation roadmap toward 2030 BOSTON–(BUSINESS WIRE)–‘Digital transformation’…
CANbridge to Present CAN106 Phase 1 Data at the European Hematology Association 2022 Congress
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals, Inc. (HKEX:1228), a China-based global biopharmaceutical company committed to…
Capstone Copper Reports First Quarter 2022 Results and Provides Consolidated Production and Cost Guidance for the Remainder of 2022
VANCOUVER, British Columbia–(BUSINESS WIRE)–Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) today announced production and…
Intercontinental Exchange Prices $8 Billion in Senior Notes and Issues Notices of Redemption for Four Series of Senior Notes due 2022 and 2023
ATLANTA & NEW YORK–(BUSINESS WIRE)–Intercontinental Exchange (NYSE: ICE), a leading global provider of data, technology…
KBRA Releases Research – KBRA Has a Clear Focus on Credit Ratings, Not ESG Scores
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases research that details its approach to environmental, social, and governance (ESG)…
KBRA Releases U.S. Bank 1Q22 Compendium
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its First-Quarter 2022 U.S. Bank Compendium. The Compendium provides our latest…
Sana Biotechnology Congratulates Senior Vice President and Head of T Cell Therapeutics, Terry Fry, M.D., on Additional Role at the University of Colorado’s Gates Institute
SEATTLE, May 12, 2022 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused…
Fulcrum Therapeutics to Present Initial Data from Phase 1b Trial of FTX-6058 in Adults Living with Sickle Cell Disease at the European Hematology Association (EHA) Hybrid Congress in Vienna, Austria
– FTX-6058 is the only oral hemoglobin F (HbF) inducer in clinical development -Data will…
Crinetics Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Phase 1 Multiple-Ascending Dose Data for CRN04894 Expected in 2Q22 Paltusotine’s Phase 3 PATHFNDR Trials…
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2022
◦ UCART20x22 preclinical data presented at AACR demonstrated PoC with robust in vitro and in vivo…
Belite Bio Announces Partial Exercise of Over-Allotment Option in Initial Public Offering
SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite” or…
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
Initial data from pivotal FIREFLY-1 study with tovorafenib (DAY101) in relapsed pediatric low-grade glioma (pLGG)…
Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update
CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a…
Checkpoint Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
Positive top-line results from registration-enabling study of cosibelimab in metastatic cutaneous squamous cell carcinoma announced…
Editas Medicine Receives FDA Orphan Drug Designation for EDIT-301 for the Treatment of Beta Thalassemia
Company on track to dose first transfusion-dependent beta thalassemia patient with EDIT-301 by year-end CAMBRIDGE, Mass.,…